vs
EXACT SCIENCES CORP（EXAS）与TUTOR PERINI CORP（TPC）财务数据对比。点击上方公司名可切换其他公司
TUTOR PERINI CORP的季度营收约是EXACT SCIENCES CORP的1.7倍（$1.5B vs $878.4M），TUTOR PERINI CORP净利率更高（1.9% vs -9.8%，领先11.7%），TUTOR PERINI CORP同比增速更快（41.2% vs 23.1%），EXACT SCIENCES CORP自由现金流更多（$120.4M vs $98.7M），过去两年TUTOR PERINI CORP的营收复合增速更高（19.9% vs 17.4%）
Exact Sciences是总部位于美国威斯康星州麦迪逊的分子诊断企业，专注于早期癌症检测领域。公司核心产品覆盖结直肠癌筛查与预防场景，其中Cologuard是全球首个获批的结直肠癌粪便DNA检测产品，同时还提供其他多种癌症的筛查服务及精准肿瘤检测解决方案。
Tutor Perini集团是美国顶尖的大型总承包商之一，2008年由Perini公司与Tutor-Saliba公司合并成立，总部位于加利福尼亚州西尔马。公司业务覆盖北美全境，2024年营收约43.3亿美元，核心业务涵盖桥梁、公路、隧道、机场、公共交通系统等民用基建项目，同时也涉足建筑工程领域。
EXAS vs TPC — 直观对比
营收规模更大
TPC
是对方的1.7倍
$878.4M
营收增速更快
TPC
高出18.1%
23.1%
净利率更高
TPC
高出11.7%
-9.8%
自由现金流更多
EXAS
多$21.7M
$98.7M
两年增速更快
TPC
近两年复合增速
17.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $878.4M | $1.5B |
| 净利润 | $-86.0M | $28.8M |
| 毛利率 | 70.1% | 9.8% |
| 营业利润率 | -9.4% | 3.3% |
| 净利率 | -9.8% | 1.9% |
| 营收同比 | 23.1% | 41.2% |
| 净利润同比 | 90.1% | 136.3% |
| 每股收益（稀释后） | $-0.45 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXASTPC
| Q4 25 | $878.4M | $1.5B | ||
| Q3 25 | $850.7M | $1.4B | ||
| Q2 25 | $811.1M | $1.4B | ||
| Q1 25 | $706.8M | $1.2B | ||
| Q4 24 | $713.4M | $1.1B | ||
| Q3 24 | $708.7M | $1.1B | ||
| Q2 24 | $699.3M | $1.1B | ||
| Q1 24 | $637.5M | $1.0B |
净利润EXASTPC
| Q4 25 | $-86.0M | $28.8M | ||
| Q3 25 | $-19.6M | $3.6M | ||
| Q2 25 | $-1.2M | $20.0M | ||
| Q1 25 | $-101.2M | $28.0M | ||
| Q4 24 | $-864.6M | $-79.4M | ||
| Q3 24 | $-38.2M | $-100.9M | ||
| Q2 24 | $-15.8M | $812.0K | ||
| Q1 24 | $-110.2M | $15.8M |
毛利率EXASTPC
| Q4 25 | 70.1% | 9.8% | ||
| Q3 25 | 68.6% | 12.0% | ||
| Q2 25 | 69.3% | 14.3% | ||
| Q1 25 | 70.8% | 10.8% | ||
| Q4 24 | 69.0% | -0.9% | ||
| Q3 24 | 69.4% | -2.4% | ||
| Q2 24 | 69.8% | 10.4% | ||
| Q1 24 | 70.0% | 11.0% |
营业利润率EXASTPC
| Q4 25 | -9.4% | 3.3% | ||
| Q3 25 | -3.0% | 2.8% | ||
| Q2 25 | -0.3% | 5.6% | ||
| Q1 25 | -13.6% | 5.2% | ||
| Q4 24 | -122.8% | -8.1% | ||
| Q3 24 | -5.6% | -9.9% | ||
| Q2 24 | -3.8% | 3.6% | ||
| Q1 24 | -16.7% | 4.7% |
净利率EXASTPC
| Q4 25 | -9.8% | 1.9% | ||
| Q3 25 | -2.3% | 0.3% | ||
| Q2 25 | -0.1% | 1.5% | ||
| Q1 25 | -14.3% | 2.2% | ||
| Q4 24 | -121.2% | -7.4% | ||
| Q3 24 | -5.4% | -9.3% | ||
| Q2 24 | -2.3% | 0.1% | ||
| Q1 24 | -17.3% | 1.5% |
每股收益（稀释后）EXASTPC
| Q4 25 | $-0.45 | $0.53 | ||
| Q3 25 | $-0.10 | $0.07 | ||
| Q2 25 | $-0.01 | $0.38 | ||
| Q1 25 | $-0.54 | $0.53 | ||
| Q4 24 | $-4.69 | $-1.53 | ||
| Q3 24 | $-0.21 | $-1.92 | ||
| Q2 24 | $-0.09 | $0.02 | ||
| Q1 24 | $-0.60 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $964.7M | $734.6M |
| 总债务越低越好 | — | $407.4M |
| 股东权益账面价值 | $2.4B | $1.2B |
| 总资产 | $5.9B | $5.2B |
| 负债/权益比越低杠杆越低 | — | 0.33× |
8季度趋势，按日历期对齐
现金及短期投资EXASTPC
| Q4 25 | $964.7M | $734.6M | ||
| Q3 25 | $1.0B | $695.7M | ||
| Q2 25 | $858.4M | $526.1M | ||
| Q1 25 | $786.2M | $276.5M | ||
| Q4 24 | $1.0B | $455.1M | ||
| Q3 24 | $1.0B | $287.4M | ||
| Q2 24 | $946.8M | $267.1M | ||
| Q1 24 | $652.1M | $358.3M |
总债务EXASTPC
| Q4 25 | — | $407.4M | ||
| Q3 25 | — | $413.1M | ||
| Q2 25 | — | $419.4M | ||
| Q1 25 | — | $405.6M | ||
| Q4 24 | — | $534.1M | ||
| Q3 24 | — | $681.4M | ||
| Q2 24 | — | $676.4M | ||
| Q1 24 | — | $801.2M |
股东权益EXASTPC
| Q4 25 | $2.4B | $1.2B | ||
| Q3 25 | $2.5B | $1.2B | ||
| Q2 25 | $2.5B | $1.2B | ||
| Q1 25 | $2.4B | $1.2B | ||
| Q4 24 | $2.4B | $1.1B | ||
| Q3 24 | $3.2B | $1.2B | ||
| Q2 24 | $3.2B | $1.3B | ||
| Q1 24 | $3.1B | $1.3B |
总资产EXASTPC
| Q4 25 | $5.9B | $5.2B | ||
| Q3 25 | $5.9B | $5.2B | ||
| Q2 25 | $5.8B | $4.9B | ||
| Q1 25 | $5.7B | $4.5B | ||
| Q4 24 | $5.9B | $4.2B | ||
| Q3 24 | $6.7B | $4.4B | ||
| Q2 24 | $6.7B | $4.3B | ||
| Q1 24 | $6.4B | $4.4B |
负债/权益比EXASTPC
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.35× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.56× | ||
| Q2 24 | — | 0.52× | ||
| Q1 24 | — | 0.61× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $151.7M | $173.7M |
| 自由现金流经营现金流 - 资本支出 | $120.4M | $98.7M |
| 自由现金流率自由现金流/营收 | 13.7% | 6.5% |
| 资本支出强度资本支出/营收 | 3.6% | 5.0% |
| 现金转化率经营现金流/净利润 | — | 6.02× |
| 过去12个月自由现金流最近4个季度 | $356.8M | $567.2M |
8季度趋势，按日历期对齐
经营现金流EXASTPC
| Q4 25 | $151.7M | $173.7M | ||
| Q3 25 | $219.9M | $289.1M | ||
| Q2 25 | $89.0M | $262.4M | ||
| Q1 25 | $30.8M | $22.9M | ||
| Q4 24 | $47.1M | $329.6M | ||
| Q3 24 | $138.7M | $22.6M | ||
| Q2 24 | $107.1M | $53.1M | ||
| Q1 24 | $-82.3M | $98.3M |
自由现金流EXASTPC
| Q4 25 | $120.4M | $98.7M | ||
| Q3 25 | $190.0M | $240.2M | ||
| Q2 25 | $46.7M | $235.6M | ||
| Q1 25 | $-365.0K | $-7.2M | ||
| Q4 24 | $10.7M | $320.4M | ||
| Q3 24 | $112.6M | $15.6M | ||
| Q2 24 | $71.2M | $42.2M | ||
| Q1 24 | $-120.0M | $87.8M |
自由现金流率EXASTPC
| Q4 25 | 13.7% | 6.5% | ||
| Q3 25 | 22.3% | 17.0% | ||
| Q2 25 | 5.8% | 17.1% | ||
| Q1 25 | -0.1% | -0.6% | ||
| Q4 24 | 1.5% | 30.0% | ||
| Q3 24 | 15.9% | 1.4% | ||
| Q2 24 | 10.2% | 3.7% | ||
| Q1 24 | -18.8% | 8.4% |
资本支出强度EXASTPC
| Q4 25 | 3.6% | 5.0% | ||
| Q3 25 | 3.5% | 3.5% | ||
| Q2 25 | 5.2% | 2.0% | ||
| Q1 25 | 4.4% | 2.4% | ||
| Q4 24 | 5.1% | 0.9% | ||
| Q3 24 | 3.7% | 0.6% | ||
| Q2 24 | 5.1% | 1.0% | ||
| Q1 24 | 5.9% | 1.0% |
现金转化率EXASTPC
| Q4 25 | — | 6.02× | ||
| Q3 25 | — | 79.63× | ||
| Q2 25 | — | 13.14× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 65.44× | ||
| Q1 24 | — | 6.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXAS
| Screening | $695.1M | 79% |
| Precision Oncology | $183.2M | 21% |
TPC
| State And Local Agencies | $591.1M | 39% |
| Mass Transit | $449.9M | 30% |
| Federal Agencies | $115.0M | 8% |
| Bridges | $100.5M | 7% |
| Military Facilities | $93.1M | 6% |
| Commercial And Industrial Facilities | $46.7M | 3% |
| Detention Facilities | $43.8M | 3% |
| Power And Energy | $35.8M | 2% |
| Multi Unit Residential | $25.9M | 2% |
| Education Facilities | $12.0M | 1% |
| Water | $3.6M | 0% |
